Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Recurrent venous thrombosis].

J N Fiessinger

    Journal Des Maladies Vasculaires
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Recurrent venous thrombosis research has shifted from risk factors to molecular pathology. Understanding hemostasis is key to diagnosing and treating this vascular disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study.

    Journal of thrombosis and haemostasis : JTH·2010
    Same author

    Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation.

    Journal of cellular and molecular medicine·2009
    Same author

    Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study.

    Journal of internal medicine·2006
    Same author

    The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study.

    Journal of thrombosis and haemostasis : JTH·2004
    Same author

    Laboratory monitoring of low-molecular-weight heparin therapy.

    Journal of thrombosis and haemostasis : JTH·2004
    Same author

    [Subintimal angioplasty. Technique, results and role in the treatment of peripheral arterial occlusive disease].

    Journal des maladies vasculaires·2004
    Same journal

    Renal function and venous thromboembolic diseases.

    Journal des maladies vasculaires·2016
    Same journal

    [Ankle-brachial index screening for peripheral artery disease in high cardiovascular risk patients. Prospective observational study of 370 asymptomatic patients at high cardiovascular risk].

    Journal des maladies vasculaires·2016
    Same journal

    [Erratum to "When to worry about before a vascular chronic leg ulcer?" [J. Mal. Vasc. 41 (2016) 307-314]].

    Journal des maladies vasculaires·2016
    Same journal

    [Deep venous thrombosis of the upper limb in a violin player: The "bow syndrome"].

    Journal des maladies vasculaires·2016
    Same journal

    [Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France].

    Journal des maladies vasculaires·2016
    Same journal

    [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?]

    Journal des maladies vasculaires·2016
    See all related articles

    Area of Science:

    • Hematology
    • Molecular Biology
    • Vascular Medicine

    Context:

    • Recurrent venous thrombosis diagnosis has evolved significantly.
    • Traditional risk factor assessment is being replaced by deeper etiological insights.
    • Advances in hemostasis research are driving this diagnostic revolution.

    Purpose:

    • To highlight the paradigm shift in understanding venous thrombosis etiology.
    • To emphasize the transition from clinical risk factors to molecular pathology.
    • To position venous thromboembolic disorder as a model for vascular disease research.

    Summary:

    • Research on recurrent venous thrombosis now focuses on its underlying molecular causes.
    • Progress in hemostasis knowledge has transformed diagnostic approaches.

    Related Experiment Videos

  • This shift enables a more precise understanding of the molecular pathology involved.

    • Impact:

    • Facilitates a move towards precision medicine in thrombotic disorders.
    • Enhances the understanding of complex vascular diseases.
    • Provides a foundation for developing novel diagnostic and therapeutic strategies.